Siemens Healthineers’ Gets EUA for Semi-Quantitative Antibody Test

The FDA has granted Siemens Healthineers an Emergency Use Authorization for a semi-quantitative SARS-CoV-2 IgG antibody test.

The antibody test is the first authorized by the FDA that gives clinicians the ability to gauge the level of IgG antibodies present in a blood sample.

The test will help to establish the level of IgG antibodies that may be protective against the coronavirus, the company said.